RARRES2 and fatty liver disease: Our results are also consistent with those published by Dahl et al. [30], Kajor et al. [38] and Krautbauer et al. [41] who demonstrated reduced visfatin and enhanced chemerin expression in the liver of individuals with hepatic steatosis and NASH compared to subjects with normal liver structure.